Combination Therapy with Ruxolitinib and Hydroxyurea for the Treatment of Myeloid-Predominant Leukocytosis in a Patient with Myelofibrosis

Giovanni Caocci; Silvia Ghiani; Cristina Mocci; Giorgio La?Nasa

首页> 外文期刊>Acta Haematologica >Combination Therapy with Ruxolitinib and Hydroxyurea for the Treatment of Myeloid-Predominant Leukocytosis in a Patient with Myelofibrosis

【24h】

Combination Therapy with Ruxolitinib and Hydroxyurea for the Treatment of Myeloid-Predominant Leukocytosis in a Patient with Myelofibrosis

机译：用ruxolitinib和羟基脲的组合治疗治疗肌纤维纤维化患者骨髓骨髓性白细胞症

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Acta Haematologica》 |2018年第3期|共2页
作者
Giovanni Caocci; Silvia Ghiani; Cristina Mocci; Giorgio La?Nasa;
展开▼
作者单位

Hematology Unit Department of Medical Sciences and Public Health University of Cagliari Cagliari;

Hematology Unit Department of Medical Sciences and Public Health University of Cagliari Cagliari;

Surgical Pathology Department A. Businco Hospital AOB Cagliari Cagliari Italy;

Hematology Unit Department of Medical Sciences and Public Health University of Cagliari Cagliari;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Combination Therapy with Ruxolitinib and Hydroxyurea for the Treatment of Myeloid-Predominant Leukocytosis in a Patient with Myelofibrosis [J] . Giovanni Caocci, Silvia Ghiani, Cristina Mocci, Acta Haematologica . 2018,第3期

机译：用ruxolitinib和羟基脲的组合治疗治疗肌纤维纤维化患者骨髓骨髓性白细胞症
2. Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis [J] . Breccia Massimo, Luciano Luigiana, Pugliese Novella, Annals of hematology . 2019,第8期

机译：劳罗替尼和羟基脲组合患者过度增殖性肌纤维纤维纤维症的疗效和安全性
3. Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis [J] . Novella Pugliese, Claudia Giordano, Davide Nappi, Cancer Medicine . 2019,第6期

机译：将羟基脲与鲁索替尼组合使用可改善骨髓纤维化过度增殖形式的临床反应
4. Antidepressants, Cognitive-Behavior Therapy And Combination Treatment For Depressed Patients: A Systematic Review And Meta-Analysis [C] . Wallace J., Byrne C., Nwosu B., Interdisciplinary Congress of the Hellenic Society for the Advancement ofPsychiatry and Related Sciences . 2014

机译：抑郁症患者的抗抑郁药，认知行为治疗和组合治疗：系统审查和荟萃分析
5. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
6. Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis [O] . Claudio Cerchione, Ilaria Peluso, Davide Nappi, -1

机译：Ruxolitinib再挑战与羟基脲联合可有效缓解原发性骨髓纤维化患者的恶病质减少输血需求和脾肿大症状
7. The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best available therapy in the treatment of myelofibrosis [O] . Mary Frances McMullin, Claire N. Harrison, Dietger Niederwieser, 2015

机译：ruxolitinib促红细胞生成素促进剂在COMFORT-II骨髓纤维化患者中的应用：一项开放性的3期研究，评估ruxolitinib相对于最佳治疗骨髓纤维化的疗效和安全性
8. Studies of Ocular Complications of AIDS (SOCA): Database Documentation for'Combination Foscarnet and Ganciclovir Therapy versus Monotherapy for the Treatment of Relapsed Cytomegalovirus Retinitis in Patients with AIDS (CRRT)' [R] . 1997

机译：艾滋病眼部并发症（sOCa）研究：“联合膦甲酸和更昔洛韦治疗与单药治疗艾滋病患者复发性巨细胞病毒性视网膜炎（CRRT）”的数据库文件

Combination Therapy with Ruxolitinib and Hydroxyurea for the Treatment of Myeloid-Predominant Leukocytosis in a Patient with Myelofibrosis

著录项

相似文献

相关主题

期刊订阅